Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Is The Current Size And Growth Outlook For The Rheumatology Therapeutics Market?

Over the past few years, the size of the rheumatology therapeutics market has seen a steady increase. It is predicted to expand from $42.4 billion in 2024 to $44.18 billion in 2025, representing a compound annual growth rate (CAGR) of 4.2%. Historical growth in this market can be traced back to factors like an increase in the incidence of rheumatologic diseases, a global rise in the aging population, heightened awareness regarding available treatments, advancements in biologic therapies, and widening healthcare accessibility in up-and-coming markets.

The market size of therapeutics in rheumatology is forecast to experience a consistent expansion in the coming few years. It is projected to reach $52.25 billion by 2029, with a compound annual growth rate (CAGR) of 4.3%. This progression during the projected period is as a result of the shift towards tailor-made medical treatment, increasing use of biosimilars in rheumatology, boosted investments in research and development, inclusion of digital health technologies, and the sanctioning of novel therapies. Looking forward, the key trends during this period are expected to be the rise of telemedicine and remote monitoring solutions, broadening of targeted treatments for specific rheumatic disorders, focus on care models that prioritize the patient, scaling up of biologic treatments beyond monoclonal antibodies, and the implementation of pricing models based on value.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17246&type=smp

What Are The Primary Factors Supporting The Rheumatology Therapeutics Market Expansion?

The growth of the rheumatology therapeutics market is anticipated to be driven by the escalating incidence of autoimmune diseases. These diseases occur when the immune system erroneously harms the body’s own tissues. A mix of genetic, environmental, and lifestyle factors, compounded by heightened awareness and superior testing capabilities, have led to an increase in autoimmune diseases. The need for rheumatology therapeutics is essential in combating autoimmune diseases to control inflammation, relieve symptoms, and halt the immune system’s assault on joints and tissues. According to the Australian Institute of Health and Welfare, a government agency based in Australia, in June 2024, around 514,000 individuals or 2.0% of Australia’s population, were projected to be suffering from rheumatoid arthritis in 2022. Rheumatoid arthritis made up 2.0% of the total disease load and 16% of the load for all musculoskeletal conditions in 2023. Consequently, the escalating prevalence of autoimmune diseases is spurring the expansion of the rheumatology therapeutics market.

What Segmentation Insights Are Provided In The Rheumatology Therapeutics Market Research?

The rheumatology therapeutics market covered in this report is segmented –

1) By Drug Class: Disease Modifying Anti-Rheumatic Drugs, Nonsteroidal Anti-Inflammatory Drugs, Corticosteroids, Uric Acid Drugs, Other Drugs Classes

2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

3) By Disease Indication: Rheumatoid Arthritis, Osteoarthritis, Gout, Psoriatic Arthritis, Ankylosing Spondylitis, Other Disease Indications

Subsegments:

1) By Disease Modifying Anti-Rheumatic Drugs (DMARDs): Conventional Synthetic DMARDs, Biologic DMARDs, Targeted Synthetic DMARDs

2) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): COX-2 Inhibitors, Traditional NSAIDs

3) By Corticosteroids: Oral Corticosteroids, Injectable Corticosteroids, Topical Corticosteroids

4) By Uric Acid Drugs: Uric Acid Lowering Agents, Uricosuric Agents, Pegloticase

5) By Other Drug Classes: Immunosuppressants, Biologic Therapies, Analgesics

Which Notable Trends Are Transforming The Rheumatology Therapeutics Market Outlook?

Leading businesses in the rheumatology therapeutics field are investing in groundbreaking treatments like intravenous (IV) formulations to improve therapeutic efficiency and patient comfort. In this context, an intravenous (IV) formulation is a therapeutic solution or substance that is directly administered into the vein via a needle or catheter. For instance, in October 2023, Novartis AG, an eminent pharmaceutical firm from Switzerland, disclosed that the US Food and Drug Administration (FDA) had validated an intravenous (IV) formulation called Cosentyx. It is exclusively sanctioned to provide relief to adults suffering from psoriatic arthritis (PsA), ankylosing spondylitis (AS), and non-radiographic axial spondyloarthritis (nr-axSpA). The drug functions by specifically targeting and hampering interleukin-17A (IL-17A). It is presently the singular non-tumor necrosis factor alpha (TNF-a) IV therapy available for these conditions.

Who Are The Major Stakeholders Operating In The Rheumatology Therapeutics Market?

Major companies operating in the rheumatology therapeutics market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Gilead Sciences Inc., Janssen Biotech, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals, UCB S.A., Galapagos NV (GLPG), Genentech Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/rheumatology-therapeutics-global-market-report

Which Regional Markets Are Emerging As Key Hubs For The Rheumatology Therapeutics Market?

North America was the largest region in the rheumatology therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rheumatology therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=17246&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model